Full Text View
Tabular View
No Study Results Posted
Related Studies
Tranexamic Acid in Clopidogrel Exposure to Decrease Hemorrhage and Transfusion (TRACED)
This study has been completed.
Study NCT01060163   Information provided by Cardiovascular Institute & Fuwai Hospital

First Received on January 28, 2010.   Last Updated on November 21, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Coronary Artery Disease
Additional conditions recognized in this trial
Coronary Disease
Myocardial Ischemia
More general conditions related to this trial
Arterial Occlusive Diseases
Arteriosclerosis
Cardiovascular Diseases
Heart Diseases
Vascular Diseases
Interventions listed in this trial
Tranexamic Acid
Saline
Additional drug interventions recognized in this trial
Anesthetics
Antifibrinolytic Agents
Clopidogrel
More general drug interventions related to this trial
Central Nervous System Agents
Central Nervous System Depressants
Coagulants
Fibrin Modulating Agents
Hematologic Agents
Hemostatics
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Platelet Aggregation Inhibitors
Purinergic Agents
Purinergic Antagonists
Purinergic P2 Receptor Antagonists
Purinergic P2Y Receptor Antagonists
Therapeutic Uses
Sponsors listed in this trial
Cardiovascular Institute & Fuwai Hospital


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services